StonvexLoading…
StonvexStonvexStonvexCore line items from EME's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $16.99B | $14.57B | $12.58B | $11.08B |
Operating Income | $1.71B | $1.34B | $875.76M | $564.88M |
Net Income | $1.27B | $1.01B | $632.99M | $406.12M |
EPS (Diluted) | $28.19 | $21.52 | $13.31 | $8.10 |
Total Assets | $9.29B | $7.72B | $6.61B | $5.52B |
Total Liabilities | $5.62B | $4.78B | $4.14B | $3.55B |
Cash & Equivalents | $1.11B | $1.34B | $789.75M | $456.44M |
Free Cash Flow OCF − CapEx | $1.19B | $1.33B | $821.25M | $448.64M |
Shares Outstanding | 44.52M | 45.81M | 47.05M | 47.67M |